Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Plaque, Atherosclerotic | 14 | 2018 | 423 | 2.86 | Why? |
| Positron-Emission Tomography | 14 | 2018 | 802 | 1.74 | Why? |
| Atherosclerosis | 15 | 2019 | 768 | 1.73 | Why? |
| Coronary Vessels | 6 | 2021 | 914 | 1.05 | Why? |
| Molecular Imaging | 3 | 2017 | 110 | 0.92 | Why? |
| Fluorodeoxyglucose F18 | 10 | 2019 | 1153 | 0.91 | Why? |
| Magnetic Resonance Imaging | 13 | 2018 | 6551 | 0.90 | Why? |
| Sodium Fluoride | 2 | 2017 | 16 | 0.87 | Why? |
| Multimodal Imaging | 8 | 2018 | 534 | 0.86 | Why? |
| Epoxide Hydrolases | 1 | 2018 | 21 | 0.73 | Why? |
| Coronary Artery Disease | 6 | 2021 | 2570 | 0.71 | Why? |
| Aortic Diseases | 3 | 2018 | 362 | 0.66 | Why? |
| Nanoparticles | 6 | 2017 | 2040 | 0.64 | Why? |
| Vascular Calcification | 2 | 2021 | 396 | 0.63 | Why? |
| Capillary Permeability | 1 | 2018 | 277 | 0.61 | Why? |
| Macrophages | 6 | 2018 | 2784 | 0.61 | Why? |
| Radiopharmaceuticals | 8 | 2018 | 763 | 0.60 | Why? |
| Carotid Stenosis | 3 | 2017 | 207 | 0.60 | Why? |
| Arteriosclerosis | 3 | 2004 | 50 | 0.57 | Why? |
| Wearable Electronic Devices | 1 | 2021 | 694 | 0.52 | Why? |
| Inflammation | 8 | 2018 | 13255 | 0.49 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.46 | Why? |
| Magnetic Resonance Angiography | 3 | 2018 | 282 | 0.46 | Why? |
| Rabbits | 8 | 2018 | 1171 | 0.45 | Why? |
| Heart Rate | 1 | 2021 | 1527 | 0.45 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.42 | Why? |
| Carotid Arteries | 3 | 2018 | 182 | 0.42 | Why? |
| Fluorine Radioisotopes | 3 | 2017 | 59 | 0.38 | Why? |
| Contrast Media | 6 | 2018 | 1011 | 0.36 | Why? |
| Amygdala | 2 | 2019 | 42 | 0.36 | Why? |
| Arteritis | 2 | 2019 | 23 | 0.36 | Why? |
| Enzyme Inhibitors | 1 | 2018 | 1881 | 0.33 | Why? |
| Cardiovascular Diseases | 7 | 2020 | 11497 | 0.31 | Why? |
| Anti-Inflammatory Agents | 4 | 2019 | 6153 | 0.31 | Why? |
| New York City | 12 | 2021 | 7432 | 0.30 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.30 | Why? |
| Nanomedicine | 3 | 2019 | 329 | 0.29 | Why? |
| Aorta | 3 | 2018 | 355 | 0.28 | Why? |
| Interleukin-2 | 1 | 2006 | 443 | 0.26 | Why? |
| Carotid Artery Diseases | 2 | 2018 | 251 | 0.26 | Why? |
| Predictive Value of Tests | 9 | 2021 | 9537 | 0.22 | Why? |
| Myocardial Ischemia | 2 | 2019 | 781 | 0.22 | Why? |
| Thrombosis | 4 | 2018 | 7504 | 0.20 | Why? |
| Permeability | 2 | 2017 | 238 | 0.20 | Why? |
| Lipoproteins, HDL | 2 | 2017 | 154 | 0.19 | Why? |
| Acetaldehyde | 1 | 2018 | 11 | 0.18 | Why? |
| Gadolinium DTPA | 1 | 2018 | 45 | 0.18 | Why? |
| Artifacts | 2 | 2017 | 250 | 0.18 | Why? |
| Malondialdehyde | 1 | 2018 | 113 | 0.17 | Why? |
| Spectrophotometry, Infrared | 1 | 2017 | 54 | 0.17 | Why? |
| Dextrans | 1 | 2017 | 35 | 0.17 | Why? |
| Glucans | 1 | 2017 | 13 | 0.17 | Why? |
| Tomography, X-Ray Computed | 9 | 2020 | 25144 | 0.17 | Why? |
| Vascular Remodeling | 1 | 2018 | 99 | 0.17 | Why? |
| Meglumine | 1 | 2017 | 26 | 0.17 | Why? |
| Simvastatin | 1 | 2017 | 63 | 0.17 | Why? |
| Acute Kidney Injury | 4 | 2021 | 5762 | 0.17 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2017 | 85 | 0.17 | Why? |
| Stress, Physiological | 1 | 2021 | 378 | 0.17 | Why? |
| Renal Elimination | 1 | 2017 | 62 | 0.16 | Why? |
| Constriction, Pathologic | 1 | 2017 | 212 | 0.16 | Why? |
| Hospitalization | 11 | 2021 | 54280 | 0.16 | Why? |
| Ferric Compounds | 1 | 2017 | 136 | 0.15 | Why? |
| Hyaluronic Acid | 1 | 2017 | 168 | 0.15 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.15 | Why? |
| Magnetic Resonance Imaging, Cine | 2 | 2017 | 669 | 0.15 | Why? |
| Graft Survival | 1 | 2018 | 587 | 0.15 | Why? |
| Renal Dialysis | 3 | 2021 | 4358 | 0.15 | Why? |
| Stress, Psychological | 4 | 2021 | 10231 | 0.15 | Why? |
| Fluorescence Resonance Energy Transfer | 1 | 2017 | 320 | 0.14 | Why? |
| Respiration Disorders | 1 | 2021 | 526 | 0.14 | Why? |
| Circadian Rhythm | 1 | 2021 | 607 | 0.14 | Why? |
| Animals | 18 | 2019 | 78931 | 0.14 | Why? |
| Aorta, Thoracic | 2 | 2015 | 271 | 0.14 | Why? |
| Organometallic Compounds | 1 | 2017 | 206 | 0.14 | Why? |
| Machine Learning | 2 | 2021 | 4395 | 0.14 | Why? |
| Social Environment | 1 | 2017 | 389 | 0.13 | Why? |
| Heptanoic Acids | 1 | 2013 | 13 | 0.13 | Why? |
| Chemistry, Pharmaceutical | 1 | 2015 | 152 | 0.13 | Why? |
| Immunity, Innate | 4 | 2020 | 6570 | 0.13 | Why? |
| Humans | 55 | 2021 | 930598 | 0.13 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 1510 | 0.13 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2017 | 665 | 0.13 | Why? |
| Sarcoidosis | 1 | 2017 | 271 | 0.13 | Why? |
| Myeloid Cells | 1 | 2018 | 808 | 0.13 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.13 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 290 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2020 | 810 | 0.13 | Why? |
| Cardiac Imaging Techniques | 1 | 2016 | 357 | 0.13 | Why? |
| Disease Models, Animal | 4 | 2018 | 10998 | 0.13 | Why? |
| Hemorrhage | 3 | 2020 | 3013 | 0.13 | Why? |
| Feasibility Studies | 3 | 2018 | 3467 | 0.12 | Why? |
| Hematopoietic Stem Cells | 1 | 2015 | 321 | 0.12 | Why? |
| Coronary Thrombosis | 1 | 2017 | 433 | 0.12 | Why? |
| Coronary Stenosis | 1 | 2016 | 273 | 0.12 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.11 | Why? |
| Prednisolone | 1 | 2015 | 443 | 0.11 | Why? |
| Mice, Knockout | 4 | 2018 | 1815 | 0.11 | Why? |
| Cell Proliferation | 2 | 2017 | 1973 | 0.11 | Why? |
| Male | 31 | 2021 | 367725 | 0.11 | Why? |
| Immunologic Memory | 2 | 2020 | 3362 | 0.11 | Why? |
| Hospital Mortality | 8 | 2021 | 22087 | 0.11 | Why? |
| Patient Readmission | 1 | 2020 | 1543 | 0.11 | Why? |
| Myocardium | 2 | 2020 | 2323 | 0.11 | Why? |
| Social Class | 1 | 2019 | 1360 | 0.11 | Why? |
| Precision Medicine | 2 | 2017 | 1477 | 0.11 | Why? |
| Anticoagulants | 3 | 2020 | 9563 | 0.10 | Why? |
| Female | 28 | 2021 | 380317 | 0.10 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Pyrroles | 1 | 2013 | 292 | 0.10 | Why? |
| Reproducibility of Results | 5 | 2017 | 11304 | 0.10 | Why? |
| Sleep Apnea, Obstructive | 1 | 2018 | 668 | 0.10 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.10 | Why? |
| Adult | 18 | 2021 | 244371 | 0.10 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.09 | Why? |
| Continuous Positive Airway Pressure | 1 | 2018 | 1187 | 0.09 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.09 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.09 | Why? |
| Tomography, Emission-Computed | 1 | 2007 | 27 | 0.09 | Why? |
| Lung | 4 | 2021 | 31049 | 0.09 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.09 | Why? |
| Arteries | 2 | 2017 | 283 | 0.09 | Why? |
| Hematopoiesis | 2 | 2019 | 168 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.09 | Why? |
| Comorbidity | 6 | 2021 | 34796 | 0.08 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2019 | 2654 | 0.08 | Why? |
| Aged | 19 | 2021 | 215776 | 0.08 | Why? |
| Technetium | 1 | 2006 | 21 | 0.08 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.08 | Why? |
| Minority Groups | 1 | 2017 | 1631 | 0.08 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.08 | Why? |
| Tissue Distribution | 2 | 2018 | 483 | 0.08 | Why? |
| Diet, High-Fat | 2 | 2018 | 161 | 0.08 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.07 | Why? |
| Mice | 7 | 2018 | 21357 | 0.07 | Why? |
| Apolipoproteins E | 2 | 2017 | 170 | 0.07 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.07 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.07 | Why? |
| Calcinosis | 1 | 2007 | 240 | 0.07 | Why? |
| Myocardial Infarction | 1 | 2020 | 3361 | 0.07 | Why? |
| Liposomes | 2 | 2017 | 334 | 0.07 | Why? |
| Positron Emission Tomography Computed Tomography | 3 | 2019 | 1458 | 0.07 | Why? |
| Organ Transplantation | 1 | 2018 | 2616 | 0.06 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.06 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.06 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.06 | Why? |
| Bone Marrow | 2 | 2017 | 492 | 0.06 | Why? |
| Imaging, Three-Dimensional | 2 | 2017 | 680 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Risk Factors | 9 | 2021 | 71621 | 0.06 | Why? |
| Mice, Inbred C57BL | 3 | 2017 | 5542 | 0.06 | Why? |
| Severity of Illness Index | 6 | 2020 | 48226 | 0.05 | Why? |
| Prognosis | 6 | 2020 | 32490 | 0.05 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.05 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.05 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Hospitals, Private | 1 | 2020 | 198 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Glucocorticoids | 1 | 2015 | 4431 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Imipramine | 1 | 2017 | 3 | 0.05 | Why? |
| Nuclear Medicine | 1 | 2006 | 585 | 0.05 | Why? |
| Tight Junction Proteins | 1 | 2017 | 16 | 0.05 | Why? |
| Hematuria | 1 | 2020 | 284 | 0.05 | Why? |
| Nucleus Accumbens | 1 | 2017 | 16 | 0.05 | Why? |
| Vimentin | 1 | 2018 | 86 | 0.05 | Why? |
| Claudin-5 | 1 | 2017 | 35 | 0.05 | Why? |
| Adrenergic Uptake Inhibitors | 1 | 2017 | 11 | 0.05 | Why? |
| Zirconium | 1 | 2017 | 10 | 0.04 | Why? |
| Vasa Vasorum | 1 | 2017 | 2 | 0.04 | Why? |
| Carbocyanines | 1 | 2017 | 13 | 0.04 | Why? |
| Image Processing, Computer-Assisted | 2 | 2017 | 1383 | 0.04 | Why? |
| Plaque, Amyloid | 1 | 2017 | 33 | 0.04 | Why? |
| Radioisotopes | 1 | 2017 | 29 | 0.04 | Why? |
| Urine | 1 | 2020 | 469 | 0.04 | Why? |
| Swimming | 1 | 2017 | 57 | 0.04 | Why? |
| Color | 1 | 2017 | 92 | 0.04 | Why? |
| Micelles | 1 | 2017 | 96 | 0.04 | Why? |
| Biomedical Engineering | 1 | 2017 | 91 | 0.04 | Why? |
| Tumor Cells, Cultured | 1 | 2017 | 254 | 0.04 | Why? |
| Behavior, Animal | 1 | 2017 | 136 | 0.04 | Why? |
| Electronic Health Records | 2 | 2020 | 3492 | 0.04 | Why? |
| Proteinuria | 1 | 2020 | 474 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2017 | 291 | 0.04 | Why? |
| Cholesterol, Dietary | 1 | 2015 | 8 | 0.04 | Why? |
| Models, Cardiovascular | 1 | 2017 | 153 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| HMGB1 Protein | 1 | 2018 | 223 | 0.04 | Why? |
| Gadolinium | 1 | 2017 | 318 | 0.04 | Why? |
| Food Preferences | 1 | 2017 | 128 | 0.04 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2018 | 385 | 0.04 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.04 | Why? |
| Lipid Metabolism | 1 | 2020 | 572 | 0.04 | Why? |
| Dideoxynucleosides | 1 | 2015 | 92 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Florida | 1 | 2018 | 598 | 0.04 | Why? |
| Chicago | 1 | 2018 | 653 | 0.04 | Why? |
| Glycolysis | 1 | 2016 | 208 | 0.04 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Allografts | 1 | 2018 | 761 | 0.04 | Why? |
| Hospitals, Urban | 1 | 2020 | 950 | 0.04 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Image Enhancement | 1 | 2016 | 177 | 0.03 | Why? |
| Half-Life | 1 | 2015 | 298 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2020 | 711 | 0.03 | Why? |
| Vascular Stiffness | 1 | 2017 | 264 | 0.03 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.03 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.03 | Why? |
| HIV | 1 | 2020 | 1116 | 0.03 | Why? |
| Blood-Brain Barrier | 1 | 2017 | 531 | 0.03 | Why? |
| Fluorescent Dyes | 1 | 2017 | 536 | 0.03 | Why? |
| Risk | 1 | 2006 | 5288 | 0.03 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.03 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.03 | Why? |
| Depression | 1 | 2017 | 14116 | 0.03 | Why? |
| Rats, Wistar | 1 | 2015 | 621 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Fibrinolysis | 1 | 2017 | 521 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2019 | 9893 | 0.03 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.03 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.03 | Why? |
| Rats, Sprague-Dawley | 1 | 2015 | 987 | 0.03 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.03 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Spleen | 1 | 2015 | 877 | 0.03 | Why? |
| Nanotechnology | 1 | 2017 | 821 | 0.03 | Why? |
| Coronary Angiography | 1 | 2021 | 2275 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
| Counseling | 1 | 2017 | 747 | 0.03 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.03 | Why? |
| Vasculitis | 1 | 2017 | 691 | 0.03 | Why? |
| Electrocardiography | 1 | 2004 | 3957 | 0.02 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2019 | 1579 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| New York | 1 | 2017 | 2488 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Rats | 1 | 2015 | 2764 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Thrombolytic Therapy | 1 | 2017 | 2218 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.02 | Why? |
| Health Education | 1 | 2017 | 1539 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Epitopes | 1 | 2018 | 4113 | 0.02 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Cells, Cultured | 1 | 2016 | 5835 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.02 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Clinical Decision-Making | 1 | 2016 | 3755 | 0.01 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.01 | Why? |
| Double-Blind Method | 1 | 2013 | 5988 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |